Methocarbamol description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Methocarbamol

Camber Pharmaceuticals, Inc.

Methocarbamol Tablets USPRx Only


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

METHOCARBAMOL DESCRIPTION



11155
Methocarbamol


CLINICAL PHARMACOLOGY


Pharmacokinetics




Special populations


Elderly


Renally impaired


Hepatically impaired

INDICATIONS & USAGE


METHOCARBAMOL CONTRAINDICATIONS


WARNINGS



(see PRECAUTIONS, Pregnancy).

Use In Activities Requiring Mental Alertness


PRECAUTIONS

Information for Patients




Drug Interactions


See WARNINGS and PRECAUTIONS

Drug & OR Laboratory Test Interactions


Carcinogenesis & Mutagenesis & Impairment Of Fertility


Pregnancy


Teratogenic effects -Pregnancy Category C

see WARNINGS

Nursing Mothers


Pediatric Use


METHOCARBAMOL ADVERSE REACTIONS



Body as a whole
Cardiovascular system
Digestive system:
Hemic and lymphatic system:
Immune system
Nervous system:
Skin and special senses

OVERDOSAGE



Treatment

Management of overdose includes symptomatic and supportive treatment. Supportive measures include maintenance of an adequate airway, monitoring urinary output and vital signs, and administration of intravenous fluids if necessary. The usefulness of hemodialysis in managing overdose is unknown.

DOSAGE & ADMINISTRATION








HOW SUPPLIED















Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].


Dispense in tight container.




Methocarbamol





PACKAGE LABEL.PRINCIPAL DISPLAY PANEL




Methocarbamol


Methocarbamol

Methocarbamol

Methocarbamol TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:31722-533
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
METHOCARBAMOL METHOCARBAMOL 500 mg

Inactive Ingredients

Ingredient Name Strength
SODIUM LAURYL SULFATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
POVIDONE K90
POLYETHYLENE GLYCOLS
MAGNESIUM STEARATE
SILICON DIOXIDE
hydroxypropyl cellulose
STEARIC ACID

Product Characteristics

Color Size Imprint Code Shape
WHITE (White to Offwhite) 15 mm 114;H OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 30 in 1 BOTTLE
2 60 in 1 BOTTLE
3 100 in 1 BOTTLE
4 500 in 1 BOTTLE
5 1000 in 1 BOTTLE
6 NDC:31722-533-10 12 in 1 CASE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090200 2013-03-20


Methocarbamol

Methocarbamol TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:31722-534
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
METHOCARBAMOL METHOCARBAMOL 750 mg

Inactive Ingredients

Ingredient Name Strength
SODIUM LAURYL SULFATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
POVIDONE K90
POLYETHYLENE GLYCOLS
MAGNESIUM STEARATE
SILICON DIOXIDE
hydroxypropyl cellulose
STEARIC ACID

Product Characteristics

Color Size Imprint Code Shape
WHITE (White to Offwhite) 19 mm 115;H OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 30 in 1 BOTTLE
2 60 in 1 BOTTLE
3 100 in 1 BOTTLE
4 500 in 1 BOTTLE
5 NDC:31722-534-05 12 in 1 CASE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090200 2013-03-20


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.